We use spermatogenesis as a model to study the genetic regulation of
germ cell development and differentiation. We also study the molecular
genetics of aberrant sexual development in human caused by mutations in
the luteinizing hormone receptor
Genetic Regulation of Spermatogenesis
Wu, Pang, Baxendale, Rennert, Chan in collaboration with Chen,a
Li,b Dym,c
Sud
Spermatogenesis is a tightly regulated process; it is characterized by
spermatogonial mitotic expansion and differentiation of stem cells, meiosis
of spermatocytes, and transformation of spermatids to spermatozoa. Specific
changes occur in the cell population, with each step resulting in a more
differentiated state. Knowledge of the factors that result in the differentiation
of germ cells will be helpful in enhancing our understanding of the biological
changes that occur during human differentiation. One of the goals of this
research is to delineate the genes that regulate spermatogenesis by using
expression gene profiling techniques, including DNA microarrays and serial
analysis of gene expression (SAGE).
We profiled the expressed genes of three germ cell populations, namely,
type A spermatogonia (spermatogonial stem cell), pachytene spermatocytes,
and round spermatids. Type A spermatogonial cells were isolated from the
testes of six-day-old mice while spermatocytes and spermatids were isolated
from the testes of 60-day-old mice by using the STAPUT technique. Highly
purified total RNA isolated from the germ cells was reverse-transcribed
and labeled with 33P-dCTP. Labeled cDNA
was hybridized to mouse GeneFilters from ResGen with 5,148 cDNA elements.
Duplicate microarray hybridizations were performed on two different preparations
of germ cells at the same stage of spermatogenesis. Only genes that gave
comparable signals between duplicate microarrays were considered to be
truly expressed. This procedure identified 79 cDNAs that can be clustered
into 12 changing patterns among the cells at the three stages of spermatogenesis
studied. Among these cDNAs, only 12 are known mouse genes, 16 are expressed
sequence tags (ESTs) with similarity to known genes, and the rest undefined
ESTs. The 10 most abundant cDNAs in type A spermatogonia are ESTs. The
large number of ESTs underscores the fact that little is known about the
genetic regulation of spermatogenesis and suggests leads for further investigation.
Germ cell RNA was also used to generate SAGE libraries. So far, we have
performed SAGE with pachytene spermatocytes. Preliminary analysis of 18,500
tags yielded classes of transcripts with distinctly different abundance.
Among the 23 most abundant transcripts (abundance of each gene was >0.2
percent of transcriptome) (Table 1), there were three tags with no match
in the mouse SAGEmap database, again suggesting that our knowledge of
genes expressed in germ cells is very limited.
Table 1: The most abundant tags (>0.2% of transcriptome)
Tag
|
Percent Abundance
|
Description
|
ATAATACATA |
0.6758 |
Novel |
GTGGCTCACA |
0.6326 |
EST |
AAACAGAGTC |
0.6056 |
t-complex-associated testis expressed
3 |
TGCCACCTGA |
0.5893 |
Y box protein 2 |
GGTCTGGCTG |
0.4217 |
Tubulin alpha 3/7 |
TGCTGAGAAT |
0.4001 |
Protein phosphatase 1, catalytic subunit,
gamma isoform |
GTAAGCATAA |
0.3947 |
Ubiquitin B |
ATACTGACAT |
0.3514 |
Novel |
GCCTTCCAAT |
0.3460 |
DEAD (aspartate-glutamate-alanine-aspartate)
box polypeptide 5 |
ACCGCTGACC |
0.3406 |
Lateate dehydrogenase 3, C chain, sperm-specific |
GTGACCACGG |
0.3298 |
Nove |
TGGAACGATA |
0.319 |
RIKEN cDNA 0710001D07 gene |
GCACAACTTG |
0.2973 |
Calmodulin 2 |
TCGATGTCTG |
0.2703 |
Protamine 2 |
CCAAATAAAA |
0.2595 |
Lactate dehydrogenase 1, A chain |
GTGTCTTACA |
0.2595 |
Meiosis expressed gene 1 |
ATGTGAGAAA |
0.2541 |
Four and one half LIM domain 4 |
CACGGCTTTC |
0.2541 |
Ribosomal protein L26 |
TGCTTCCTCC |
0.2433 |
RIKEN cDNA 1700010P14 gene |
GTAAGCAAA |
0.2379 |
Ubiquitin B |
TGTCTTCTGT |
0.2379 |
Testis-specific gene 1 |
TGAACTTTGA |
0.2162 |
ESTs |
TAACTGACAA |
0.2108 |
Metallothionein 2 |
We will continue to analyze germ cell transcriptomes at different stages
of spermatogenesis and study the change of the transcriptome of germ cells
under different experimental conditions that affect spermatogenesis. We
will also investigate the effect of abrogation of some of the selected
genes on spermatogenesis. In addition, we plan within the coming year
to generate a SAGE database for mouse germ cell genes.
Physiological and Genetic Effects of Constitutively Activated Luteinizing
Hormone Receptor
Zhang, Pang, Wu, Rennert, and Chan in collaboration with Leschek,e
Martin, and Sud
Constitutively activating mutations of the human luteinizing hormone/chorionic
gonadotropin hormone receptor (LHR) causes familial male-limited precocious
puberty (FMPP). We have identified two FMPP patients who developed testicular
neoplasia. To study the impact of constitutive activation of the LH/hCG
signaling pathway on spermatogenesis and sexual development and the potential
tumorigenic effect of a constitutively activated LHR, we have generated
an in vitro cell model and are in the process of generating a transgenic
animal model. The mouse Leydig cells, MA-10, were transfected with an
LHR carrying an activating mutation. The profile of expressed genes in
cells expressing the mutated LHR was compared with that of control cells.
Preliminary studies showed several genes associated with cell proliferation,
e.g., CDC23, phosphatidylinositol transfer protein alpha, and a gene known
to be located in the multiple endocrine neoplasia type 1 site were up-regulated,
and two cell differentiation genes, namely, the Slit2 gene and the inducible
GTPase Ral-B gene, were down-regulated in MA-10 cells expressing a constitutively
activated hLHR (Table 2). Interestingly, two genes known to be involved
in spermatogenesis, namely, Vav-T gene and tpr1, were also down-regulated
in cells expressing the mutated LHR. We are now repeating this study with
LHR carrying different activating mutations and by using a more extensive
mouse cDNA microarray. In addition to the in vitro study, we are
generating constructs of LHR carrying activating mutations for introduction
into mouse ES cells to generate a transgenic animal model of FMPP for
the study of the impact of constitutively activated LHR gene on spermatogenesis
and sexual development.
Table 2: Genes affected by hLHR-Asp578Tyr
![](graphics/spacer.gif) |
|
Up-Regulated
Genes
CDC23
Phospholipase C b3 neighboring gene
located in the MEN1 site
Phosphatidylinositol transfer protein alpha
Down-Regulated Genes
Neurogenic extracellular slit protein (Slit2)
Inducible GTPase Ral-B mRNA
Vav-T gene |
![](graphics/spacer.gif) |
|
|
PUBLICATIONS
- Leschek
EW, Chan WY, Diamond D, Laefer M, Jones J, Barnes KM, Cutler GBJr.
Nodular Leydig cell hyperplasia in a boy with familial male-limited
precocious puberty (FMPP). J Pediatr 2001;38:949-951.
- Wu SM, Leschek EW, Rennert OM, Chan WY. Genetics of the luteinizing
hormone receptor mutations in sexual development/cancer. J Pediat Path
Molec Med 2000;19:21-40.
- Wu
SM, Leschek EW, Rennert OM, Chan WY. Luteinizing hormone receptor
mutations in disorders of sexual development and cancer. Frontiers Biosci
2000;5:D342-352.
a Yali Chen, Georgetown University,
Washington, D.C.
b Xiaoquan Li, Georgetown University,
Washington, D.C.
c Martin Dym, Georgetown University,
Washington, D.C.
d Yan A. Su, Georgetown University, Washington,
D.C.
e Ellen W. Leschek, NICHD
f Malcolm M. Martin, Georgetown University,
Washington, D.C.
|